The present invention relates to the use of dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention of atrial fibrillation wherein said use comprises the following precaution of use steps:a) initiating dronedarone administration in patients with atrial fibrillation or atrial flutter,b) performing electrocardiograms serially.